Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
US govt doesn’t have remdesivir patent rights, says GAO
Americas
The US government doesn't co-own patents covering Gilead Science’s drug remdesivir, according to a report by the Government Accountability Office.   1 April 2021
Arthrex prevails in patent dispute over wrist fracture device
Medtech
In a win for medical device maker Arthrex, a federal judge in Delaware has ruled that its wrist-plating system does not infringe a patent owned by competitor TriMed Technologies.   30 March 2021
Lundbeck loses €150m pay-for-delay appeal
Europe
Lundbeck has lost an appeal to the Court of Justice of the European Union (CJEU) to waive €150 million ($176 million) in fines levied against itself and a group of five generics manufacturers over ‘pay-for-delay’ deals for its antidepressant generics.   30 March 2021
Big Pharma
The World Health Organization has warned the public of the danger of counterfeit COVID-19 vaccines and urged people not to procure jabs outside of government channels.   29 March 2021
Americas
The Federal Circuit has affirmed a Patent Trial and Appeal Board decision denying Stanford University a patent application for calculating parent genes.   26 March 2021
Big Pharma
The US Supreme Court has denied a petition from Argentum Pharmaceuticals to review a Federal Circuit ruling covering a multiple sclerosis treatment patent.   25 March 2021
Americas
In a win for a subsidiary of Abbott Laboratories, St Jude Medical, a US federal court has ruled that it did not infringe a patent for a catheter system owned by Niazi Licensing.   25 March 2021
Americas
Snyders Heart Valve has been successful in reviving patent claims in an on-going dispute against St Jude Medical.   25 March 2021
article
Wilson Sonsini & Rosati has hired Mark Bellomy as a partner for the firm’s technology transaction practice in Boston.   23 March 2021
Americas
Massachusetts-based biotechnology start-up Pyxis Oncology has secured a licensing deal with Pfizer for two of the pharmaceutical giant’s antibody-drug conjugates.   22 March 2021